Literature DB >> 24451376

The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway.

David Polito1, Scott Cukras, Xiaozhe Wang, Paige Spence, Lisa Moreau, Alan D D'Andrea, Younghoon Kee.   

Abstract

Fanconi anemia (FA) is a genome instability syndrome characterized by bone marrow failure and cellular hypersensitivity to DNA cross-linking agents. In response to DNA damage, the FA pathway is activated through the cooperation of 16 FA proteins. A central player in the pathway is a multisubunit E3 ubiquitin ligase complex or the FA core complex, which monoubiquitinates its substrates FANCD2 and FANCI. FANCE, a subunit of the FA core complex, plays an essential role by promoting the integrity of the complex and by directly recognizing FANCD2. To delineate its role in substrate ubiquitination from the core complex assembly, we analyzed a series of mutations within FANCE. We report that a phenylalanine located at the highly conserved extreme C terminus, referred to as Phe-522, is a critical residue for mediating the monoubiquitination of the FANCD2-FANCI complex. Using the FANCE mutant that specifically disrupts the FANCE-FANCD2 interaction as a tool, we found that the interaction-deficient mutant conferred cellular sensitivity in reconstituted FANCE-deficient cells to a similar degree as FANCE null cells, suggesting the significance of the FANCE-FANCD2 interaction in promoting cisplatin resistance. Intriguingly, ectopic expression of the FANCE C terminus fragment alone in FA normal cells disrupts DNA repair, consolidating the importance of the FANCE-FANCD2 interaction in the DNA cross-link repair.

Entities:  

Keywords:  DNA Damage; DNA Repair; E3 Ubiquitin Ligase; Protein Degradation; Protein Dynamics; Protein Folding; Protein Targeting; Protein-protein Interactions; Ubiquitin

Mesh:

Substances:

Year:  2014        PMID: 24451376      PMCID: PMC3945361          DOI: 10.1074/jbc.M113.533976

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  FANCE: the link between Fanconi anaemia complex assembly and activity.

Authors:  Paul Pace; Mark Johnson; Wu Meng Tan; Georgina Mosedale; Chelvin Sng; Maureen Hoatlin; Johan de Winter; Hans Joenje; Fanni Gergely; K J Patel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

2.  Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.

Authors:  Susan M Gordon; Manuel Buchwald
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

3.  S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.

Authors:  Toshiyasu Taniguchi; Irene Garcia-Higuera; Paul R Andreassen; Richard C Gregory; Markus Grompe; Alan D D'Andrea
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

4.  FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.

Authors:  Susan M Gordon; Noa Alon; Manuel Buchwald
Journal:  J Biol Chem       Date:  2005-08-26       Impact factor: 5.157

5.  The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex.

Authors:  I Garcia-Higuera; Y Kuang; J Denham; A D D'Andrea
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

6.  Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.

Authors:  Massimo Bogliolo; Beatrice Schuster; Chantal Stoepker; Burak Derkunt; Yan Su; Anja Raams; Juan P Trujillo; Jordi Minguillón; María J Ramírez; Roser Pujol; José A Casado; Rocío Baños; Paula Rio; Kerstin Knies; Sheila Zúñiga; Javier Benítez; Juan A Bueren; Nicolaas G J Jaspers; Orlando D Schärer; Johan P de Winter; Detlev Schindler; Jordi Surrallés
Journal:  Am J Hum Genet       Date:  2013-04-25       Impact factor: 11.025

7.  A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair.

Authors:  Nobuko Matsushita; Hiroyuki Kitao; Masamichi Ishiai; Naoki Nagashima; Seiki Hirano; Katsuya Okawa; Tomohiko Ohta; David S Yu; Peter J McHugh; Ian D Hickson; Ashok R Venkitaraman; Hitoshi Kurumizaka; Minoru Takata
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

8.  Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.

Authors:  XiaoZhe Wang; Paul R Andreassen; Alan D D'Andrea
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.

Authors:  Toshiyasu Taniguchi; Marc Tischkowitz; Najim Ameziane; Shirley V Hodgson; Christopher G Mathew; Hans Joenje; Samuel C Mok; Alan D D'Andrea
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

10.  Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage.

Authors:  Dechen Fu; Fred Duafalia Dudimah; Jun Zhang; Anna Pickering; Jayabal Paneerselvam; Manikandan Palrasu; Hong Wang; Peiwen Fei
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

View more
  13 in total

Review 1.  The Fanconi anemia ID2 complex: dueling saxes at the crossroads.

Authors:  Rebecca A Boisvert; Niall G Howlett
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  Structure of the FA core ubiquitin ligase closing the ID clamp on DNA.

Authors:  Shengliu Wang; Renjing Wang; Christopher Peralta; Ayat Yaseen; Nikola P Pavletich
Journal:  Nat Struct Mol Biol       Date:  2021-03-08       Impact factor: 15.369

3.  Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.

Authors:  Settara C Chandrasekharappa; Steven B Chinn; Frank X Donovan; Naweed I Chowdhury; Aparna Kamat; Adebowale A Adeyemo; James W Thomas; Meghana Vemulapalli; Caroline S Hussey; Holly H Reid; James C Mullikin; Qingyi Wei; Erich M Sturgis
Journal:  Cancer       Date:  2017-07-05       Impact factor: 6.860

4.  The FA Core Complex Contains a Homo-dimeric Catalytic Module for the Symmetric Mono-ubiquitination of FANCI-FANCD2.

Authors:  Paolo Swuec; Ludovic Renault; Aaron Borg; Fenil Shah; Vincent J Murphy; Sylvie van Twest; Ambrosius P Snijders; Andrew J Deans; Alessandro Costa
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.995

Review 5.  Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy.

Authors:  Ukhyun Jo; Hyungjin Kim
Journal:  Mol Cells       Date:  2015-07-21       Impact factor: 5.034

6.  The genetic and biochemical basis of FANCD2 monoubiquitination.

Authors:  Eeson Rajendra; Vibe H Oestergaard; Frédéric Langevin; Meng Wang; Gillian L Dornan; Ketan J Patel; Lori A Passmore
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

7.  Damaged mitochondria in Fanconi anemia - an isolated event or a general phenomenon?

Authors:  Giovanni Pagano; Pavithra Shyamsunder; Rama S Verma; Alex Lyakhovich
Journal:  Oncoscience       Date:  2014-04-21

Review 8.  Update of the human and mouse Fanconi anemia genes.

Authors:  Hongbin Dong; Daniel W Nebert; Elspeth A Bruford; David C Thompson; Hans Joenje; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2015-11-24       Impact factor: 4.639

9.  Dearth and Delayed Maturation of Testicular Germ Cells in Fanconi Anemia E Mutant Male Mice.

Authors:  Chun Fu; Khurshida Begum; Philip W Jordan; Yan He; Paul A Overbeek
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

10.  FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase-3 dependent degradation.

Authors:  David W Clark; Kaushlendra Tripathi; Josephine C Dorsman; Komaraiah Palle
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.